MURALI RAMASWAMY
Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease GREENSBORO, NC NPI 1013994797
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease NC Boehringer Ingelheim Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$38,835.52
- Category: General Payments
- Program years: PY2018–2024
- Record count: 380
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $3,041.43 across 47 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,139.58 | 1 |
| Food and Beverage | $901.85 | 46 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,191.32 | 5 |
| Acerta Pharma LLC | $156.79 | 7 |
| Insmed, Inc. | $111.15 | 5 |
| Amgen Inc. | $89.52 | 4 |
| Relypsa, Inc. | $67.69 | 3 |
| United Therapeutics Corporation | $65.53 | 3 |
| GlaxoSmithKline, LLC. | $60.35 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $56.65 | 3 |
| Grifols USA, LLC | $47.35 | 2 |
| GENZYME CORPORATION | $39.74 | 1 |
| INOGEN, INC. | $32.36 | 4 |
| Mylan Specialty L.P. | $32.04 | 2 |
| Merck Sharp & Dohme Corporation | $31.75 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.23 | 1 |
| Actelion Pharmaceuticals US, Inc. | $19.91 | 1 |
| Shionogi Inc | $19.05 | 1 |
By program year
Records — PY2024 (47)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.